CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Op-Ed

The Nuffield Council on Bioethics has taken what it clearly regards as a brave new step: it has openly endorsed the use of genome editing to engineer the traits of future children and generations. The council’s report, Genome editing...

Biopolitical Times
The popularity of direct-to-consumer (DTC) genetic testing by companies such as 23andMe and Ancestry.com has skyrocketed. Meanwhile, so has concern about the privacy and uses of the genetic information being amassed. As controversies build, several state and federal initiatives are bringing to light...
Press Statement

The first baby born as a result of in vitro fertilization (IVF) celebrates her 40th birthday on July 25. This...

Aggregated News

On Wednesday, President Donald Trump announced an end to administration’s policy of separating families at the border. But the...

Biopolitical Times

The California Institute for Regenerative Medicine (CIRM) is running out of money. It is also running out of time to...

Biopolitical Times used to have a regular feature called “Gene of the Week,” in which we skewered the...

News

By Rebecca Gale, Dame [Cites CGS' Marcy Darnovsky] | 08.14.2018

In our on-demand era of reproductive liberty and technology, a child’s sex isn’t always left up to chance. As more parents have the option of choosing the sex of their baby before getting pregnant, they’re walking headfirst into an ethical...

By Adam Rutherford, The Guardian | 08.10.2018

In 1884, at the International Health Exhibition in South Kensington, four million punters came to view the latest scientific marvels: drainage systems, flushing toilets and electrically illuminated fountains. There, the scientist Francis Galton set up the Anthropometric Laboratory, where...

By Antonio Regalado, MIT Technology Review | 08.08.2018

Facing criticism from fellow scientists, the researcher behind the world’s largest effort to edit human embryos with CRISPR is vowing to continue his efforts to develop what he calls “IVF gene therapy.”

Shoukhrat Mitalipov, of Oregon Health Sciences University in...

By Katie Hasson, GeneWatch | 08.06.2018

A wave of controversy about reproductive gene editing gathered force in response to reports in 2015 of the first CRISPR experiments on human embryos. That news provoked two kinds of reactions: on the one hand, hyperbolic claims about "editing humanity"...

Video

World Forum on Science and Democracy
San Francisco discussion - Gattaca at 20: Looking Back, Looking Ahead w/ a Disability Justice Focus
Berkeley discussion - Gattaca at 20: Looking Back, Looking Ahead